The major aim for the development of the DermaInspect® was skin cancer diagnosis. Using the revolutionary non-invasive multiphoton technology the physician receives detailed information on living cells and tissue structures within their natural environment. Dermatological disorders and melanoma can now be detected with submicron spatial resolution. Combined with a short image acquisition time of only a few minutes. DermaInspect® exhibits the capability to revolutionize today's long and invasive diagnosis procedures. The system can also be used for direct tissue engineering as well as in cosmetical and pharmaceutical research. The FLIM option provides a further contrast mechanism for in situ drug monitoring. Researchers will have an exclusive four-dimensional view on biological processes in living tissue.
right: 3D reconstruction of elastin and collagen structures in tissue engineered heart valves
公司新闻
